Newtyn Management, LLC 13D and 13G filings for Sensei Biotherapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-03-07 6:00 pm Sale |
2024-03-05 | 13D | Sensei Biotherapeutics, Inc. SNSE |
Newtyn Management, LLC | 1,242,245 4.950% |
-214,428 (-14.72%) |
Filing |
| 2024-02-13 5:34 pm Sale |
2024-02-09 | 13D | Sensei Biotherapeutics, Inc. SNSE |
Newtyn Management, LLC | 1,456,673 5.830% |
-277,485 (-16.00%) |
Filing |
| 2023-11-03 5:03 pm Purchase |
2023-10-25 | 13D | Sensei Biotherapeutics, Inc. SNSE |
Newtyn Management, LLC | 1,734,158 6.500% |
1,734,158 (New Position) |
Filing |